You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 5,292,724


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,292,724
Title: Intraocular anticoagulant including antithrombin III and method of administration
Abstract:An intraocular anticoagulant including antithrombin III is applicable as an injection into the ocular chamber of the eye at the time of cataract surgery, intraocular lens implant surgery, and other ocular surgeries. The anticoagulant prevents fibrin deposits from forming on the intraocular lens surface after surgery and avoids postoperative viscoelastic material inducing transient elevation in intraocular pressure.
Inventor(s): Kita; Kiyoshi (Honmachi, Shibuyaku, Tokyo, JP)
Application Number:07/904,506
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 5,292,724

Introduction

Understanding the claims and patent landscape of a specific patent is crucial for navigating the complex world of intellectual property. This analysis will delve into the details of United States Patent 5,292,724, examining its claims, the broader patent landscape, and the implications for innovation and competition.

Overview of the Patent

United States Patent 5,292,724, though not specified in the provided sources, typically involves a detailed description of an invention, including its claims, specifications, and drawings. For any patent, the claims are the most critical part as they define the scope of the invention.

Claims Analysis

Claim Structure

Patent claims are divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. A thorough analysis of these claims helps in understanding the invention's scope and its potential for patentability and enforceability[4].

Subject Matter Eligibility

Under 35 U.S.C. § 101, the subject matter eligibility of a patent is a critical issue. The Supreme Court's "Alice" test is a two-step framework used to determine if a patent claims patent-ineligible subject matter. Step 2A of this framework, particularly Prong Two, is crucial for demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem[1].

Patent Landscape Analysis

Geographical Spread and Saturation

A patent landscape analysis involves assessing the geographical spread and saturation of the technology area. This helps in understanding the global competition and the potential for innovation. For example, if the technology area is highly saturated, it may be challenging to secure new patents, and alternative technologies might need to be explored[3].

Competitors and New Entrants

Identifying competitors and new entrants in the patent space is vital. This includes analyzing the patent portfolios of key players and monitoring new filings to anticipate market trends and potential threats or opportunities.

Time-Slicing and Trends

Time-slicing involves analyzing patent activity over time to identify trends and changes in the technology area. This can reveal areas that are being abandoned or those that are gaining traction, helping in strategic decision-making[3].

Practical Applicability and Technological Advancement

Prong Two of Step 2A

For AI inventions and other complex technologies, demonstrating practical applicability under Prong Two of Step 2A is essential. This involves showing that the claims are directed to a specific technological advancement or solution to a technical problem. Practitioners must craft compelling narratives that emphasize the invention’s real-world impact and its contribution to the technological field[1].

Director Review and PTAB Decisions

Impact on Patent Landscape

The Director Review (DR) process at the USPTO can significantly impact the patent landscape. Recent trends show that the Director has favored DR requests from petitioners, especially those related to institution denials. This can affect the validity and enforceability of patents, including those in the same technology area as the patent in question[2].

Strategic Insights from Patent Landscape Analysis

Identifying Niche Areas

A comprehensive patent landscape analysis can uncover underappreciated niche areas within a technology space. This helps companies in identifying potential areas for innovation and investment that may have less competition[3].

Counseling Decision-Makers

The insights from a patent landscape analysis are crucial for counseling management or clients on the potential rewards or perils of entering a particular technology space. It guides decisions on research, development, and patent prosecution.

Case Law and Judicial Precedents

Federal Circuit and Supreme Court Decisions

Judicial decisions, such as those from the Federal Circuit and the Supreme Court, play a significant role in shaping the patent landscape. For instance, the "Alice" test and subsequent decisions have clarified the subject matter eligibility criteria, affecting how patents are evaluated and enforced[4].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of patent claims is essential for determining the invention's patentability and enforceability.
  • Subject Matter Eligibility: Demonstrating practical applicability under Prong Two of Step 2A is critical for overcoming section 101 rejections.
  • Patent Landscape: Analyzing the geographical spread, saturation, and trends in the technology area helps in strategic decision-making.
  • Competitor Analysis: Identifying competitors and new entrants is vital for anticipating market trends and potential threats or opportunities.
  • Judicial Impact: Judicial decisions significantly influence the patent landscape and the validity of patents.

FAQs

Q: What is the significance of Prong Two of Step 2A in patent subject matter eligibility analysis? A: Prong Two of Step 2A is crucial for demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem, which is essential for overcoming section 101 rejections, especially for AI inventions[1].

Q: How does patent landscape analysis help in strategic decision-making? A: Patent landscape analysis provides insights into the geographical spread, saturation, and trends in a technology area, helping companies identify potential areas for innovation, assess competition, and make informed decisions about research and development[3].

Q: What is the role of the Director Review process in the USPTO? A: The Director Review process allows for the review of PTAB decisions, with recent trends showing a focus on institution denials and a slight favor towards petitioners. This can impact the validity and enforceability of patents[2].

Q: How do judicial decisions affect the patent landscape? A: Judicial decisions, such as those from the Federal Circuit and the Supreme Court, clarify subject matter eligibility criteria and other patent law issues, significantly influencing how patents are evaluated and enforced[4].

Q: What are the key questions to answer in a patent landscape analysis? A: Key questions include determining the geographical spread of a technology patent area, assessing the saturation level, identifying new entrants, analyzing changes over time, and uncovering underappreciated niche areas[3].

Sources

  1. The Importance of Prong Two of Step 2A for AI Inventions - Baker Botts
  2. A Look at Key USPTO Director Review Decisions and their Significance - IPWatchdog
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP
  4. EcoFactor - United States Court of Appeals for the Federal Circuit - CAFC
  5. United States Patent (19) 11 Patent Number: 5,897,880 - Patent Images Storage

More… ↓

⤷  Subscribe

Details for Patent 5,292,724

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc THROMBATE III antithrombin iii (human) For Injection 103196 December 30, 1991 ⤷  Subscribe 2008-07-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.